エソテリック検査の市場規模、シェア、動向分析レポート：タイプ別、技術別、最終用途別、地域別、セグメント予測、2024年～2030年

エソテリック検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、エソテリック検査の世界市場規模は、2024年から2030年にかけてCAGR 11.81％で拡大し、2030年には479億8,000万米ドルに達すると予測されています。

市場成長の主な要因としては、がんの有病率の上昇、安全で効果的な検査に対するニーズの高まりなどが挙げられます。国際がん研究機関の報告によると、2020年には19,292,789人のがん患者が記録され、2025年には50,550,287人に増加すると推定されています。最も多く報告されているがんは、乳がん、大腸がん、肺がん、前立腺がん、胃がんです。

さらに、難解なDNAシーケンシング技術の進歩に助けられた慢性疾患や感染症の有病率の上昇は、市場全体の成長をさらに促進すると予測されています。例えば、CDCによると、心臓病は米国における主要な死因であり、33秒に1人の割合で死亡しています。さらに、National Diabetes Statistics Reportによると、米国では全人口の11.6％が糖尿病を患っています。このような主要感染症の高い有病率は、エソテリック検査の需要を促進すると予想されます。

高い有効性と特異性、高い信号強度、優れた精度、高い正確性などの利点に起因するエソテリック検査への嗜好の高まりは、予測期間中に高度な検査の需要を促進すると予測されます。さらに、早期疾患診断のために医師や患者の間でエソテリック検査機器に対する認識が高まっています。このシフトは検査の採用を大幅に後押しし、市場成長を促進すると予測されます。

さらに、予防医療に対する嗜好や意識の高まりに伴うヘルスケア支出の増加が、市場の成長を後押ししています。例えば、米国では、医療費負担適正化法（ACA）が、推奨される予防サービスに対する保険プランを提供することで、人々が利用しやすく手頃な価格で医療を受けられるよう支援しています。さらに、疾病管理への患者の参加の増加やエビデンスに基づく治療へのシフトも市場の成長に寄与しています。

同様に、これらの検査は希少疾患を特定する簡単な方法です。したがって、人口の希少疾患罹患率の増加が市場拡大を後押しすると予想されます。米国保健社会福祉省の発表によると、米国では新たに約2,205人の西ナイルウイルス感染症患者が発生しています。感染症に対するエソテリック検査はこれらの希少疾患を容易に検出できるため、エソテリック検査市場は成長しています。意識向上キャンペーン、検診プログラム、特定のがんスキームなど、政府主催のイニシアチブは、診断症例数を増加させると予測されています。例えば、インドの保健大臣がん患者基金（HMCPF）プログラムは、恵まれないがん患者を財政的に支援しています。これにより、エソテリック検査の需要が増加し、地域の成長が促進されると予想されます。

市場で事業を展開する主な企業は、疾病の予防と早期診断の需要の高まりに対応するため、常に新規製品の開発に注力しています。例えば、2023年7月、Quest Diagnostics社は、堅牢なNGSサポートサービス、注文、1対1の遺伝子検査へのアクセスを含む独自の機能を備えた消費者主導型遺伝子検査の発売を発表しました。さらに、大手企業は地理的拡大に注力し、存在感を高め、効果的な製品へのアクセスを拡大しています。例えば、2022年6月、SRL Diagnostics社はインドのチェンナイ、アショク・ナガールにリファレンスラボを開設しました。この20,000平方フィートのラボでは、広範な検査から未確認検査、遺伝子検査まで、毎月1,000件以上の検査を実施できます。

エソテリック検査市場レポートハイライト

• タイプ別では、がん診断におけるエソテリック検査の顕著な応用により、2023年にはがん分野が市場を独占し、遺伝子検査分野は予測期間中に最も速いCAGRで成長すると予測されます。
• 技術別では、化学発光免疫測定技術分野が2023年の市場を独占しました。しかし、酵素結合免疫吸着測定法は予測期間中に最も速い成長を示すと予測されています。
• 最終用途別では、2023年に独立系検査室および基準検査室セグメントが最大のシェアを占めました。しかし、病院ベースの検査室は予測期間中に最も速い成長を示すと予測されています。
• 北米は、感染症罹患率の上昇、質の高いヘルスケアに対する政府の支援、高い購買力、効率的な償還シナリオなどの要因により、市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 エソテリック検査市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• エソテリック検査市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 エソテリック検査市場：タイプ別の推定・動向分析

• セグメントダッシュボード
• 世界のエソテリック検査市場の変動分析
• 世界のエソテリック検査市場タイプ別展望
• 腫瘍学検査
• 感染症検査
• 遺伝子検査
• 内分泌検査
• 毒性試験
• 神経学的検査
• その他

第5章 エソテリック検査市場：技術別の推定・動向分析

• セグメントダッシュボード
• 世界のエソテリック検査市場の変動分析
• 世界のエソテリック検査市場技術別展望
• 化学発光免疫測定法
• 酵素免疫測定法
• 質量分析
• リアルタイムポリメラーゼ連鎖反応
• フローサイトメトリー
• その他

第6章 エソテリック検査市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 世界のエソテリック検査市場の変動分析
• 最終用途別世界のエソテリック検査市場展望
• 病院内ラボ
• 独立系およびリファレンスラボ
• その他

第7章 エソテリック検査市場：地域別の推定・動向分析

• 地域市場ダッシュボード
• 市場規模と予測動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要ディストリビューターおよびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023年
  • Laboratory Corporation of America Holdings
  • OPKO Health, Inc.
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • HU Group Holdings, Inc.
  • Kindstar Globalgene Technology, Inc.
  • Stanford Health Care
  • Mayo Foundation for Medical Education and Research
  • ARUP Laboratories.
  • Athena Esoterix
  • ACM Global Laboratories
  • Healius Limited.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America esoteric testing market, by region, 2018 - 2030 (USD Million)
• Table 3 North America esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 6 U.S. esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 12 Europe esoteric testing market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 14 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 15 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 16 Germany esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 17 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 18 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 22 France esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 23 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 24 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 25 Italy esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 26 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 27 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 28 Spain esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 29 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 30 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 31 Denmark esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 32 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 33 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 34 Sweden esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 35 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 36 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 37 Norway esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 38 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 39 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific esoteric testing market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 44 China esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 45 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 46 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 47 Japan esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 50 India esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 51 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 52 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 53 South Korea esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 54 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 55 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 56 Australia esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 59 Thailand esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 60 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 61 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 62 Latin America esoteric testing market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 64 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 65 Latin America surgical ablation market, by end use, 2018 - 2030 (USD Million)
• Table 66 Brazil esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 67 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 68 Brazil surgical ablation market, by end use, 2018 - 2030 (USD Million)
• Table 69 Mexico esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 70 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 71 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)
• Table 72 Argentina esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 73 Argentina Esoteric Testing market, by technology, 2018 - 2030 (USD Million)
• Table 74 Argentina surgical ablation market, by end use, 2018 - 2030 (USD Million)
• Table 75 MEA esoteric testing market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 77 MEA esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 78 MEA esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 79 South Africa esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 85 UAE esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
• Table 88 Kuwait esoteric testing market, by type, 2018 - 2030 (USD Million)
• Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
• Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Esoteric testing market: market outlook
• Fig. 14 Esoteric testing competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Penetration and growth prospect mapping
• Fig. 18 Industry value chain analysis
• Fig. 19 Esoteric testing market driver impact
• Fig. 20 Esoteric testing market restraint impact
• Fig. 21 Esoteric testing market strategic initiatives analysis
• Fig. 22 Esoteric testing market: Type movement analysis
• Fig. 23 Esoteric testing market: Type outlook and key takeaways
• Fig. 24 Oncology testing market estimates and forecast, 2018 - 2030
• Fig. 25 Infectious disease testing estimates and forecast, 2018 - 2030
• Fig. 26 Genetic testing market estimates and forecast, 2018 - 2030
• Fig. 27 Endocrinology testing estimates and forecast, 2018 - 2030
• Fig. 28 Toxicology testing market estimates and forecast, 2018 - 2030
• Fig. 29 Neurology testing market estimates and forecast, 2018 - 2030
• Fig. 30 Others estimates and forecast, 2018 - 2030
• Fig. 31 Esoteric testing Market: Technology movement Analysis
• Fig. 32 Esoteric testing market: Technology outlook and key takeaways
• Fig. 33 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
• Fig. 34 Mass spectrometry market estimates and forecasts, 2018 - 2030
• Fig. 35 Enzyme-linked immunosorbent assay market estimates and forecasts, 2018 - 2030
• Fig. 36 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
• Fig. 37 Flow cytometry market estimates and forecasts, 2018 - 2030
• Fig. 38 Others market estimates and forecasts, 2018 - 2030
• Fig. 39 Esoteric testing market: End use movement analysis
• Fig. 40 Esoteric testing market: End use outlook and key takeaways
• Fig. 41 Hospital-based laboratories market estimates and forecasts, 2018 - 2030
• Fig. 42 Independent and reference laboratories market estimates and forecasts, 2018 - 2030
• Fig. 43 Others market estimates and forecasts, 2018 - 2030
• Fig. 44 Global esoteric testing market: Regional movement analysis
• Fig. 45 Global esoteric testing market: Regional outlook and key takeaways
• Fig. 46 Global esoteric testing market share and leading players
• Fig. 47 North America market share and leading players
• Fig. 48 Europe market share and leading players
• Fig. 49 Asia Pacific market share and leading players
• Fig. 50 Latin America market share and leading players
• Fig. 51 Middle East & Africa market share and leading players
• Fig. 52 North America: SWOT
• Fig. 53 Europe SWOT
• Fig. 54 Asia Pacific SWOT
• Fig. 55 Latin America SWOT
• Fig. 56 MEA SWOT
• Fig. 57 North America, by country
• Fig. 58 North America
• Fig. 59 North America market estimates and forecasts, 2018 - 2030
• Fig. 60 U.S. Key Country Dynamics
• Fig. 61 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 62 Canada Key Country Dynamics
• Fig. 63 Canada market estimates and forecasts, 2018 - 2030
• Fig. 64 Europe
• Fig. 65 Europe market estimates and forecasts, 2018 - 2030
• Fig. 66 UK Key Country Dynamics
• Fig. 67 UK market estimates and forecasts, 2018 - 2030
• Fig. 68 Germany Key Country Dynamics
• Fig. 69 Germany market estimates and forecasts, 2018 - 2030
• Fig. 70 France Key Country Dynamics
• Fig. 71 France market estimates and forecasts, 2018 - 2030
• Fig. 72 Italy Key Country Dynamics
• Fig. 73 Italy market estimates and forecasts, 2018 - 2030
• Fig. 74 Spain Key Country Dynamics
• Fig. 75 Spain market estimates and forecasts, 2018 - 2030
• Fig. 76 Denmark Key Country Dynamics
• Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 78 Sweden Key Country Dynamics
• Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 80 Norway Key Country Dynamics
• Fig. 81 Norway market estimates and forecasts, 2018 - 2030
• Fig. 82 Asia Pacific
• Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 84 China Key Country Dynamics
• Fig. 85 China market estimates and forecasts, 2018 - 2030
• Fig. 86 Japan Key Country Dynamics
• Fig. 87 Japan market estimates and forecasts, 2018 - 2030
• Fig. 88 India Key Country Dynamics
• Fig. 89 India market estimates and forecasts, 2018 - 2030
• Fig. 90 Thailand Key Country Dynamics
• Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 92 South Korea Key Country Dynamics
• Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 94 Australia Key Country Dynamics
• Fig. 95 Australia market estimates and forecasts, 2018 - 2030
• Fig. 96 Latin America
• Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 98 Brazil Key Country Dynamics
• Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 100 Mexico Key Country Dynamics
• Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 102 Argentina Key Country Dynamics
• Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 104 Middle East and Africa
• Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 106 South Africa Key Country Dynamics
• Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 108 Saudi Arabia Key Country Dynamics
• Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 110 UAE Key Country Dynamics
• Fig. 111 UAE market estimates and forecasts, 2018 - 2030
• Fig. 112 Kuwait Key Country Dynamics
• Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 114 Market share of key market players- esoteric testing market

Esoteric Testing Market Growth & Trends:

The global esoteric testing market size is anticipated to reach USD 47.98 billion by 2030, expanding at a CAGR of 11.81% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth include rising prevalence of cancer and growing need for safe and effective tests. The International Agency for Research on Cancer reports that 19,292,789 cancer cases were recorded in 2020 and estimates that number will rise to 50,550,287 by 2025. The most frequently reported cancers are breast, colorectal, lung, prostate, and stomach.

Moreover, the rising prevalence of chronic and infectious diseases aided by the advancements in esoteric DNA sequencing technologies is further anticipated to drive overall growth of the market. For instance, according to CDC, heart disease are leading cause of death in the U.S., and accounts for the death of one person every 33 seconds. Furthermore, according to the National Diabetes Statistics Report, 11.6% of the total population in the U.S. suffer from diabetes. Such a high prevalence of major infectious diseases is anticipated to drive the demand for esoteric testing.

The growing preference for esoteric testing, attributed to advantages like high efficacy and specificity, high signal intensity, good precision, and high accuracy, is projected to drive the demand for advanced tests during the forecast period. Furthermore, rising awareness of esoteric testing devices among physicians and patients for early disease diagnosis. This shift is anticipated to substantially boost the adoption of tests, thereby driving market growth.

Moreover, the rising healthcare expenditure aided with rising preference and awareness regarding preventive healthcare is fueling the growth of the market. For example, the Affordable Care Act (ACA) helps in providing accessible and affordable for people in U.S. by providing insurance plans for recommended preventive services. Additionally, the growing patient participation in disease management and the shift towards evidence-based treatment are also contributing to the growth of the market.

Similarly, these tests are a simple way to identify rare diseases. Therefore, the population's increasing incidence of rare diseases is anticipated to support market expansion. As per the U.S. Department of Health and Human Services, around 2,205 new West Nile virus disease cases in the U.S. The esoteric testing market is growing because esoteric tests for infectious diseases can easily detect these rare diseases. Government-sponsored initiatives, including awareness campaigns, screening programs, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, India's Health Minister Cancer Patient Fund (HMCPF) program financially assists deprived cancer patients. This is anticipated to increase demand for esoteric testing and promote regional growth.

Key players operating in the market are constantly focusing on development of novel products to meet the rising demand for preventive and early diseases diagnosis. For instance, in July 2023, Quest Diagnostics announced the launch of consumer-initiated genetic tests with unique feature including robust NGS support services, ordering, and access to one-on-one genetic testing. Moreover, major players are focusing on geographic expansion to enhance their presence and expand access to effective products. For instance, in June 2022, SRL Diagnostics opened a reference laboratory in Ashok Nagar, Chennai, India. The 20,000-square-foot laboratory can perform over one lakh monthly tests, ranging from widespread examinations to unidentified and genetic tests.

Esoteric Testing Market Report Highlights:

• Based on type, the oncology segment dominated the market in 2023 owing to prominent application of esoteric testing in cancer diagnosis and genetic testing segment is expected to grow at the fastest CAGR over the forecast period
• Based on technology, the chemiluminescence immunoassay technology segment dominated the market in 2023. However, enzyme-linked immunosorbent assay is anticipated to witness fastest growth over the forecast period
• Based on end-use, the independent and reference laboratories segment held the largest share in 2023. However, hospital-based laboratories is anticipated to witness fastest growth over the forecast period
• North America dominated the market owing to factors such as rising incidence of infectious diseases, government support for quality healthcare, high purchasing power, and efficient reimbursement scenario

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Technology outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of infectious disease
    • 3.2.1.2. Technological advancements in esoteric testing
    • 3.2.1.3. Increasing per capita income
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled healthcare professional in developing countries
    • 3.2.2.2. Stringent regulatory framework
• 3.3. Esoteric Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Esoteric Testing Market Movement Analysis
• 4.3. Global Esoteric Testing Market by Type Outlook
• 4.4. Oncology testing
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Infectious disease testing
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Genetic testing
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Endocrinology testing
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Toxicology testing
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Neurology testing
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Esoteric Testing Market Movement Analysis
• 5.3. Global Esoteric Testing Market by Technology Outlook
• 5.4. Chemiluminescence immunoassay
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Enzyme-linked immunosorbent assay
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Mass spectrometry
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Real time polymerase chain reaction
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Flow cytometry
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Esoteric Testing Market Movement Analysis
• 6.3. Global Esoteric Testing Market by End-use Outlook
• 6.4. Hospital-based laboratories
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
• 6.5. Independent and reference laboratories
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Laboratory Corporation of America Holdings
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. OPKO Health, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Quest Diagnostics Incorporated
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Sonic Healthcare Limited
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. H.U. Group Holdings, Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Kindstar Globalgene Technology, Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Stanford Health Care
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Mayo Foundation for Medical Education and Research
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. ARUP Laboratories.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Athena Esoterix
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. ACM Global Laboratories
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
    • 8.3.14.3. Product benchmarking
  • 8.3.14. Healius Limited.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives